How to Cite
Abstract
Androgenic anabolic steroids are synthetic drugs derived from testosterone, which were created for therapeutic purposes in the beginning. At present, the indiscriminate use of them for non-clinical purposes has become a global public health problem according to the main entities in charge in the health area, since the abuse of these substances entails risks and medical implications of great clinical importance, which leads to a high economic cost in the health field, and negative repercussions in the world of sport.
Keywords
References
Aguila, Mercado, Palma C. Esteroides Androgénicos Anabolizantes: Consecuencias en el hombre. Rev.Chil.Urol. 2013;78(4).
Snyder P. Use of androgens and other hormones by athletes. [Internet]. Waltham, MA: Matsumoto A, Martin K; 22 May 2018 [Consultado el 08 Enero 2020]. Disponible en: https://www.uptodate.com
Melnik B, Jansen T, Grabbe S. Abuse of anabolic-androgenic steroids and bodybuilding acne: an underestimated health problem. JDDG; 2007;5:110–117. https://doi.org/10.1111/j.1610-0387.2007.06176.x
Martínez Ortellado H. Uso de Esteroides Anabólicos en Jóvenes de Asunción. Mem. Inst. Investig. Cienc. Salud. 2017;15(1):57-62. https://doi.org/10.18004/Mem.iics/1812-9528/2017.015(01)57-062
John E. Hall, Arthur C. Guyton. Guyton & Hall, Tratado de fisiología médica. Duodécima edición. Jackson, Mississippi: Elsevier Inc; 2011.
J. Larry Jameson, Dennis L. Kasper, Dan L. Longo, Anthony S. Fauci, Stephen L. Hauser, Joseph Loscalzo. Harrison´s Principles of internal medicine. 20th Edition. USA: Mc Graw Hill Education; 2018.
P. Lorenzo, A. Moreno, I. Lizasoain, J.C. Leza, M.A. Moro, A. Portolés. Velásquez Farmacología básica y clínica. 18ª Edición. Buenos Aires, Argentina: Médica Panamericana; 2008
Finkelstein J, Lee H, Burnett-Bowie S, Pallais C, W. Yu E, Borges L, Jones B, Barry C, K Wulczyn, Thomas B, Leder B. Gonadal Steroids and Body Composition, Strength, and Sexual Function in Men. N Engl J Med 2013;369:1011-22. https://doi.org/10.1056/NEJMoa1206168
Basaria S, Coviello A, Travison T, Storer T, Farwell W, Jette A, Eder R, Tennstedt S, Ulloor J, Zhang A, Choong K, Lakshman K, Mazer N, Miciek R, Krasnoff J, Elmi A, Knapp P, Brooks B, Appleman E, Aggarwal S, Bhasin G, Hede-Brierley L, Bhatia A, Collins L, LeBrasseur N, Fiore L, Bhasin S. Adverse Events Associated with Testosterone Administration. N Engl J Med 2010;363:109-22. https://doi.org/10.1056/NEJMoa1000485
Solbach P, Potthoff A, Raatschen H-J, Soudah B, Lehmann U, Schneider A, J. Gebel M, P. Manns M, Vogel A. Testosterone-receptor positive hepatocellular carcinoma in a 29-year old bodybuilder with a history of anabolic androgenic steroid abuse: a case report. BMC Gastroenterology.2015;15(60). https://doi.org/10.1186/s12876-015-0288-0
Djordjevi† V, Stankovi I, Vlahovi-Stipac A, Putnikovi B, Babi‡ R, N. Neškovi A. The impact of anabolic androgenic steroids abuse and type of training on left ventricular remodeling and function in competitive athletes. Vojnosanit Pregl 2014; 71(4): 383–389. https://doi.org/10.2298/VSP130504046I
Oberlander J, Porter D, Penatti C, Henderson L. Anabolic Androgenic Steroid Abuse: Multiple Mechanisms of Regulation of GABAergic Synapses in Neuroendocrine Control Regions of the Rodent Forebrain. Journal of Neuroendocrinology 2011; 24, 202–214. https://doi.org/10.1111/j.1365-2826.2011.02151.x
Alhadad A, Acosta S, Sarabi L, Ko ̈lbel T. Pulmonary Embolism Associated With Protein C Deficiency and Abuse of Anabolic-androgen Steroids. Clinical and Applied Thrombosis/Hemostasis 2010;16(2). Disponible en: http://cath.sagepub.com
Martin N, Abu Dayyeh B, Chung R. Anabolic steroid abuse causing recurrent hepatic adenomas and hemorrhage. World J Gastroenterol 2008 July 28; 14(28): 4573-4575. https://doi.org/10.3748/wjg.14.4573
Wadthaisong M, Witayavanitkul N, Bupha T, Wattanapermpool J, P.deTombe P. Chronic high-dose testosterone treatment: impact on rat cardiac contractile biology. Physiol Rep,2019; 7(14), e14192. https://doi.org/10.14814/phy2.14192
Pontes Santos R, Pereira A, Guedes H, Lourenço C, Azevedo J, Pinto P. Anabolic Drugs and Myocardial Infarction – A Clinical Case Report. Arq Bras Cardiol. 2015; 105(3):316-319. https://doi.org/10.5935/abc.20150111
Díaz Conde M. Paro cardiaco repentino atribuido a miocardiopatía hipertrófica por uso de esteroides anabólicos. Reporte de caso. Med. crít. (Col. Mex. Med. Crít.) 2017; 31(2). Disponible en: http://www.scielo.org.mx/scielo.php?script=sci_arttext&pid=S2448-89092017000200101
Hope V, Veigh J, Marongiu A, Michael Evans-Brown M, S, Kimergård A, Croxford S, Beynon C, Parry J, Bellis M, Ncube F. Prevalence of, and risk factors for, HIV, hepatitis B and C infections among men who inject image and performance enhancing drugs: a cross-sectional study. BMJ Open 2013;3: e003207. https://doi.org/10.1136/bmjopen-2013-003207
Ireland, R. Anabolic steroid abuse can lead to focal segmental glomerulosclerosis. Nat Rev Nephrol 6, 130 (2010). https://doi.org/10.1038/nrneph.2010.5
B. Jensen A, E. Haas R. Refractory Hypotension in a Patient with a History of Anabolic Steroid Abuse Taking an Angiotensin-II Receptor Blocker: A Case Report. AANA Journal October 2017;85(5). Disponible en: www.aana.com/aanajournalonline.
Pope HG Jr, Wood RI, Rogol A. Adverse health consequences of performance-enhancing drugs: an Endocrine Society scientific statement. Endocr Rev 2014; 35:341. https://doi.org/10.1210/er.2013-1058
Kanayama G, Brower KJ, Wood RI. Treatment of anabolic-androgenic steroid dependence: Emerging evidence and its implications. Drug Alcohol Depend 2010; 109(6). https://doi.org/10.1016/j.drugalcdep.2010.01.011